Stocks News

LAST PRICE
354.4100
TODAY'S CHANGE (%)
Trending Down-6.0200 (-1.6702%)

Bid / Lots
325.1700/ 1
Ask / Lots
400.0000/ 2
Open / Previous Close
360.0100 / 360.4300
Day Range
Low 353.6300
High 362.1600
52 Week Range
Low 310.4200
High 415.7300
Volume
516,095
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 26, 2024
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  11:34 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average rating of outperform and price targets ranging from $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and eco...
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  10:56 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic ...
Apr 25, 2024
- West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised, from 8:34AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:34AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: WST
  08:34 AM EDT, 04/25/2024 (MT Newswires) -- West Pharmaceutical Services (WST) reported Q1 adjusted earnings Thursday of $1.56 per diluted share, down from $1.98 a year earlier. Analysts polled by Capital IQ expected $1.29. Net sales for the quarter...
- --Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400, from 7:05AM ET on Thursday Apr 25, 2024 by MT Newswires
  7:05AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: WST
  07:05 AM EDT, 04/25/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...
- -- Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M, from 6:35AM ET on Thursday Apr 25, 2024 by MT Newswires
  6:35AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: WST
  06:35 AM EDT, 04/25/2024 (MT Newswires) -- ...

Apr 26, 2024
- Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: ALGN
- Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire
  8:30AM ET on Friday Apr 26, 2024 by Business Wire
  Companies Mentioned: ALGN
Apr 25, 2024
- --Baird Adjusts Price Target on Align Technology to $370 From $333, from 8:18AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:18AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: ALGN
- --Leerink Partners Adjusts Price Target on Align Technology to $349 From $327, from 8:17AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:17AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: ALGN
- --Piper Sandler Adjusts Price Target on Align Technology to $375 From $355, from 8:06AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:06AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: ALGN
- --Morgan Stanley Raises Price Target on Align Technology to $360 From $344, Keeps Overweight Rating, from 7:10AM ET on Thursday Apr 25, 2024 by MT Newswires
  7:10AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: ALGN
- --Goldman Sachs Adjusts Price Target on Align Technology to $250 From $225, from 7:00AM ET on Thursday Apr 25, 2024 by MT Newswires
  7:00AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: ALGN
Apr 24, 2024
- Align Technology Q1 Non-GAAP Earnings, Revenue Rise; Q2 Revenue Guidance, Stock Buyback Set; Shares Rise After Hours, from 4:27PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:27PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ALGN
- -- Earnings Flash (ALGN) ALIGN TECHNOLOGY Posts Q1 EPS $2.14, vs. Street Est of $1.97, from 4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ALGN
- -- Earnings Flash (ALGN) ALIGN TECHNOLOGY Posts Q1 Revenue $997.4M, vs. Street Est of $973.8M, from 4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ALGN

West Pharmaceutical Services Inc
NYSE:WSTUnited States

Search Criteria

Apr 26, 2024

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Apr 25, 2024

West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised, from 8:34AM ET on Thursday Apr 25, 2024 by MT Newswires

--Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400, from 7:05AM ET on Thursday Apr 25, 2024 by MT Newswires

-- Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M, from 6:35AM ET on Thursday Apr 25, 2024 by MT Newswires

Peers Headlines

Apr 26, 2024

Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire

Apr 25, 2024

--Baird Adjusts Price Target on Align Technology to $370 From $333, from 8:18AM ET on Thursday Apr 25, 2024 by MT Newswires

--Leerink Partners Adjusts Price Target on Align Technology to $349 From $327, from 8:17AM ET on Thursday Apr 25, 2024 by MT Newswires

--Piper Sandler Adjusts Price Target on Align Technology to $375 From $355, from 8:06AM ET on Thursday Apr 25, 2024 by MT Newswires

--Morgan Stanley Raises Price Target on Align Technology to $360 From $344, Keeps Overweight Rating, from 7:10AM ET on Thursday Apr 25, 2024 by MT Newswires

--Goldman Sachs Adjusts Price Target on Align Technology to $250 From $225, from 7:00AM ET on Thursday Apr 25, 2024 by MT Newswires

Apr 24, 2024

Align Technology Q1 Non-GAAP Earnings, Revenue Rise; Q2 Revenue Guidance, Stock Buyback Set; Shares Rise After Hours, from 4:27PM ET on Wednesday Apr 24, 2024 by MT Newswires

-- Earnings Flash (ALGN) ALIGN TECHNOLOGY Posts Q1 EPS $2.14, vs. Street Est of $1.97, from 4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires

-- Earnings Flash (ALGN) ALIGN TECHNOLOGY Posts Q1 Revenue $997.4M, vs. Street Est of $973.8M, from 4:02PM ET on Wednesday Apr 24, 2024 by MT Newswires